Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors.
Pommier
Y
Y
Laboratory of Molecular Pharmacology (DTP, DCT), National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
Leteurtre
F
F
Fesen
M R
MR
Fujimori
A
A
Bertrand
R
R
Solary
E
E
Kohlhagen
G
G
Kohn
K W
KW
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis; D001483:Base Sequence; D002453:Cell Cycle; D004249:DNA Damage; D004351:Drug Resistance; D006801:Humans; D008956:Models, Chemical; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors
D000970:Antineoplastic Agents; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors